On the evening of October 6, Dr. Chun Yu told reporters on the phone that the company is now normal. Because the founder died unfortunately, the first step is to do a good job of Zhang’s aftermath. There may be personnel changes in the follow-up. In terms of investment, the company will have a board of directors composed of investors to make a judgment on this matter. “Mr. Zhang Rui is a pioneer in the field of Internet in China. From “Jinghua Times†to Netease to Dr. Chun Yu, Mr. Zhang Rui accurately grasped the two opportunities of Internet revolution and successfully realized from “connecting people and information†to connecting people. In the August of this year, Mr. Zhang Rui also put his eyes on the upcoming era of Internet of Everything.†Dr. Chun Yu said in his obituary on October 6. However, for Dr. Chun Yu, how to face the post-Zhang Rui era will be a subject that has to be faced. On the evening of October 6, Dr. Chun Yu told reporters on the phone that the company is now normal. Because the founder died unfortunately, the first step is to do a good job of Zhang’s aftermath. There may be personnel changes in the follow-up. In terms of investment, the company will have a board of directors composed of investors to make a judgment on this matter. Zhang Rui There are many well-known investors behind Zong Peimin, a well-known domestic venture capitalist and chairman of Zhejiang Huarui Investment Management Co., Ltd., said in an interview with the reporter of “Daily Economic News†that an innovative project like Chunyu Medical needs a strong entrepreneurial leadership to gather wisdom. Capital and talent can form a lever of perseverance and creative methods, and the death of the founder is fatal to any innovation and entrepreneurship project, unless there is a successor with the same entrepreneurial characteristics. On June 24, Dr. Chun Yu introduced that the company is preparing for Pre-IPO. According to media reports, Dr. Chun Yu has completed the 1.2 billion financing Pre-IPO link. In 2015, the actual income of the online consultation business reached 130 million yuan, and the profit was 30 million yuan. The company has planned to split the market, but has not decided to choose A. Stocks or the new three board market. On the other hand, Zhang Rui said in an interview that he did not have a listing intention, which is more of a demand from the capital side. According to Tencent Technology, behind the spin-off of Dr. Chun Yu, investors have put a lot of pressure on them. After five years of entrepreneurship, the investors of Chunyu doctors need to see the return, and the spin-off will become a compromise solution. However, the relevant person of Dr. Chun Yu told reporters that the company is now normal. Because the founder died unfortunately, the first step is to do a good job of Zhang’s aftermath. The deceased is big. Don’t have too much speculation. In terms of investment, the company will A board of directors consisting of investors made a judgment on the matter. Angiography Drape,Surgery Angiography Drape,Disposable Angiography Drape,Sterile Surgical Angiography Drape Xinxiang Huaxi Sanitary Materials Co., Ltd. , https://www.huaximedical.com